$172.32
00.00%
Pre-Market: Jul 19, 5:26 PM EDT
15 minutes delayed
Comments
Loading...
AbbVie
ABBVNYSE
AbbVie (NYSE:ABBV) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | ABBV | AbbVie | FY | 2024 | $10.61 | $10.81 | $11.25 | — | — | — | Get Alert |
| 07/03/2024 | ABBV | AbbVie | Q2 | 2024 | $2.53 | $2.57 | $3.05 | — | — | — | Get Alert |
| 04/26/2024 | ABBV | AbbVie | FY | 2024 | $11.13 | $11.33 | $11.10 | $55.00B | $55.00B | $54.60B | Get Alert |
| 04/26/2024 | ABBV | AbbVie | Q2 | 2024 | $3.05 | $3.09 | $2.81 | $14.00B | $14.00B | $13.57B | Get Alert |
| 04/03/2024 | ABBV | AbbVie | Q1 | 2024 | $2.18 | $2.22 | $2.33 | — | — | — | Get Alert |
| 04/03/2024 | ABBV | AbbVie | FY | 2024 | $10.97 | $11.17 | $11.19 | — | — | — | Get Alert |
| 02/12/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.18 | — | — | — | Get Alert |
| 02/12/2024 | ABBV | AbbVie | Q1 | 2024 | $2.26 | $2.30 | $2.39 | — | — | — | Get Alert |
| 02/02/2024 | ABBV | AbbVie | Q1 | 2024 | $2.30 | $2.34 | $2.31 | $11.90B | $11.90B | $11.37B | Get Alert |
| 02/02/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.24 | $54.20B | $54.20B | $49.94B | Get Alert |
| 01/05/2024 | ABBV | AbbVie | FY | 2023 | $11.04 | $11.08 | $11.22 | — | — | — | Get Alert |
| 01/05/2024 | ABBV | AbbVie | Q4 | 2023 | $2.72 | $2.76 | $2.90 | — | — | — | Get Alert |
| 10/27/2023 | ABBV | AbbVie | FY | 2023 | $11.19 | $11.23 | $10.42 | — | — | — | Get Alert |
| 10/27/2023 | ABBV | AbbVie | FY | 2024 | $11.00 | $11.00 | $10.45 | — | — | — | Get Alert |
| 10/04/2023 | ABBV | AbbVie | FY | 2023 | $10.86 | $11.06 | $11.07 | — | — | — | Get Alert |
| 10/04/2023 | ABBV | AbbVie | Q3 | 2023 | $2.76 | $2.86 | $2.88 | — | — | — | Get Alert |
| 07/27/2023 | ABBV | AbbVie | Q3 | 2023 | $2.80 | $2.90 | $2.82 | $13.70B | $13.70B | $13.35B | Get Alert |
| 07/27/2023 | ABBV | AbbVie | FY | 2023 | $10.90 | $11.10 | $10.87 | — | — | — | Get Alert |
| 07/06/2023 | ABBV | AbbVie | FY | 2023 | $10.57 | $10.97 | $10.08 | — | — | — | Get Alert |
| 07/06/2023 | ABBV | AbbVie | Q2 | 2023 | $2.75 | $2.85 | $2.69 | — | — | — | Get Alert |
| 04/27/2023 | ABBV | AbbVie | Q2 | 2023 | $2.90 | $3.00 | $2.85 | $13.50B | $13.50B | $13.36B | Get Alert |
| 04/27/2023 | ABBV | AbbVie | FY | 2023 | $10.72 | $11.12 | $10.94 | — | — | — | Get Alert |
| 04/05/2023 | ABBV | AbbVie | FY | 2023 | $10.62 | $11.02 | $11.07 | — | — | — | Get Alert |
| 04/05/2023 | ABBV | AbbVie | Q1 | 2023 | $2.31 | $2.41 | $2.55 | — | — | — | Get Alert |
| 02/09/2023 | ABBV | AbbVie | Q1 | 2023 | $2.39 | $2.49 | $3.08 | $11.80B | $11.80B | $13.36B | Get Alert |
| 02/09/2023 | ABBV | AbbVie | FY | 2024 | $10.70 | — | — | — | — | — | Get Alert |
| 02/09/2023 | ABBV | AbbVie | FY | 2023 | $10.70 | $11.10 | $11.65 | $52.00B | $52.00B | $54.21B | Get Alert |
| 01/06/2023 | ABBV | AbbVie | FY | 2022 | $13.70 | $13.74 | $13.85 | — | — | — | Get Alert |
| 01/06/2023 | ABBV | AbbVie | Q4 | 2022 | $3.51 | $3.55 | $3.67 | — | — | — | Get Alert |
| 10/28/2022 | ABBV | AbbVie | FY | 2022 | $13.84 | $13.88 | $13.86 | $58.20B | $58.20B | $58.92B | Get Alert |
| 10/28/2022 | ABBV | AbbVie | Q4 | 2022 | $3.65 | $3.69 | $3.75 | $15.20B | $15.20B | $15.78B | Get Alert |
| 10/05/2022 | ABBV | AbbVie | FY | 2022 | $13.76 | $13.96 | $13.87 | — | — | — | Get Alert |
| 10/05/2022 | ABBV | AbbVie | Q3 | 2022 | $3.53 | $3.57 | $3.60 | — | — | — | Get Alert |
| 07/29/2022 | ABBV | AbbVie | Q3 | 2022 | $3.55 | $3.59 | $3.67 | $14.80B | $14.80B | $15.28B | Get Alert |
| 07/29/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $13.91 | $58.90B | $58.90B | $59.59B | Get Alert |
| 07/06/2022 | ABBV | AbbVie | Q2 | 2022 | $3.24 | $3.28 | $3.43 | — | — | — | Get Alert |
| 07/06/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $14.01 | — | — | — | Get Alert |
| 04/29/2022 | ABBV | AbbVie | Q2 | 2022 | $3.38 | $3.42 | $3.47 | $14.60B | $14.60B | $14.77B | Get Alert |
| 04/29/2022 | ABBV | AbbVie | FY | 2022 | $13.92 | $14.12 | $14.11 | $59.40B | $59.40B | $60.04B | Get Alert |
| 02/02/2022 | ABBV | AbbVie | FY | 2022 | $14.00 | $14.20 | $13.99 | — | — | — | Get Alert |
| 10/29/2021 | ABBV | AbbVie | FY | 2021 | $12.63 | $12.67 | $12.59 | $56.20B | $56.20B | $56.28B | Get Alert |
| 10/29/2021 | ABBV | AbbVie | Q4 | 2021 | $3.24 | $3.28 | $3.30 | $15.00B | $15.00B | $15.01B | Get Alert |
| 07/30/2021 | ABBV | AbbVie | FY | 2021 | $12.52 | $12.62 | $12.60 | — | — | — | Get Alert |
| 04/30/2021 | ABBV | AbbVie | Q2 | 2021 | $3.05 | $3.09 | $3.06 | $13.60B | $13.60B | $13.52B | Get Alert |
| 04/30/2021 | ABBV | AbbVie | FY | 2021 | $12.37 | $12.57 | $12.45 | $55.90B | $55.90B | $55.34B | Get Alert |
| 02/03/2021 | ABBV | AbbVie | FY | 2021 | $12.32 | $12.52 | $12.18 | — | — | — | Get Alert |
| 10/30/2020 | ABBV | AbbVie | Q4 | 2020 | $2.83 | $2.85 | $2.90 | $13.80B | $13.80B | $13.69B | Get Alert |
| 10/30/2020 | ABBV | AbbVie | FY | 2020 | $10.47 | $10.49 | $10.42 | $45.70B | $45.70B | $45.49B | Get Alert |
| 07/31/2020 | ABBV | AbbVie | FY | 2020 | $10.35 | $10.45 | $10.32 | — | — | — | Get Alert |
| 05/08/2020 | ABBV | AbbVie | FY | 2020 | — | — | — | $50.00B | $50.00B | — | Get Alert |
| 05/01/2020 | ABBV | AbbVie | FY | 2020 | $9.61 | $9.71 | $9.48 | — | — | — | Get Alert |
| 05/01/2020 | ABBV | AbbVie | Q2 | 2020 | $2.10 | $2.16 | $2.25 | — | — | — | Get Alert |
| 02/07/2020 | ABBV | AbbVie | FY | 2020 | $9.61 | $9.71 | $9.48 | $35.93B | $35.93B | $35.06B | Get Alert |
| 02/07/2020 | ABBV | AbbVie | Q1 | 2020 | $2.28 | $2.30 | $2.12 | — | — | — | Get Alert |
| 11/01/2019 | ABBV | AbbVie | Q4 | 2019 | $2.17 | $2.19 | $2.21 | — | — | — | Get Alert |
| 11/01/2019 | ABBV | AbbVie | FY | 2019 | $8.90 | $8.92 | $8.90 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for AbbVie (ABBV)?
The last reported Earnings numbers were from July 3, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $10.61 and $10.81 versus the estimated EPS of $11.25.
Browse guidance and forecast on all stocks.